Skip to main content
Top

Breast Cancer Research

Issue 5/2006

Content (15 Articles)

Commentary

Recent translational research: circulating tumor cells in breast cancer patients

Volkmar Müller, Daniel F Hayes, Klaus Pantel

Open Access Research article

Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy

Lorenzo Preda, Gaetano Villa, Stefania Rizzo, Luca Bazzi, Daniela Origgi, Enrico Cassano, Massimo Bellomi

Open Access Research article

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

David G Cox, Hélène Blanché, Celeste L Pearce, Eugenia E Calle, Graham A Colditz, Malcolm C Pike, Demetrius Albanes, Naomi E Allen, Pilar Amiano, Goran Berglund, Heiner Boeing, Julie Buring, Noel Burtt, Federico Canzian, Stephen Chanock, Françoise Clavel-Chapelon, Heather Spencer Feigelson, Matthew Freedman, Christopher A Haiman, Susan E Hankinson, Brian E Henderson, Robert Hoover, David J Hunter, Rudolf Kaaks, Laurence Kolonel, Peter Kraft, Loic LeMarchand, Eiliv Lund, Domenico Palli, Petra HM Peeters, Elio Riboli, Daniel O Stram, Michael Thun, Anne Tjonneland, Dimitrios Trichopoulos, Meredith Yeager

Open Access Research article

Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study

Anne Stuedal, Giske Ursin, Marit B Veierød, Yngve Bremnes, Janne E Reseland, Christian A Drevon, Inger T Gram

Open Access Research article

Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data

Anita Grigoriadis, Alan Mackay, Jorge S Reis-Filho, Dawn Steele, Christian Iseli, Brian J Stevenson, C Victor Jongeneel, Haukur Valgeirsson, Kerry Fenwick, Marjan Iravani, Maria Leao, Andrew JG Simpson, Robert L Strausberg, Parmjit S Jat, Alan Ashworth, A Munro Neville, Michael J O'Hare

Erratum

Erratum to: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Elisabetta Munzone, Giuseppe Curigliano, Andrea Rocca, Giuseppina Bonizzi, Giuseppe Renne, Aron Goldhirsch, Franco Nolè

Open Access Research article

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome

Eleni Mylona, Christina Magkou, Ioanna Giannopoulou, George Agrogiannis, Sofia Markaki, Antonios Keramopoulos, Lydia Nakopoulou

Open Access Research article

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

Greg Finak, Svetlana Sadekova, Francois Pepin, Michael Hallett, Sarkis Meterissian, Fawaz Halwani, Karim Khetani, Margarita Souleimanova, Brent Zabolotny, Atilla Omeroglu, Morag Park

Open Access Research article

CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

Carol Sheridan, Hiromitsu Kishimoto, Robyn K Fuchs, Sanjana Mehrotra, Poornima Bhat-Nakshatri, Charles H Turner, Robert Goulet Jr, Sunil Badve, Harikrishna Nakshatri

Open Access Research article

Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

Tanja Fehm, Sven Becker, Graziella Becker-Pergola, Karl Sotlar, Gerhard Gebauer, Silke Dürr-Störzer, Hans Neubauer, Diethelm Wallwiener, Erich-Franz Solomayer

Open Access Research article

Classification of ductal carcinoma in situ by gene expression profiling

Juliane Hannemann, Arno Velds, Johannes BG Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver

Open Access Research article

Predicting a local recurrence after breast-conserving therapy by gene expression profiling

Dimitry SA Nuyten, Bas Kreike, Augustinus AM Hart, Jen-Tsan Ashley Chi, Julie B Sneddon, Lodewyk FA Wessels, Hans J Peterse, Harry Bartelink, Patrick O Brown, Howard Y Chang, Marc J van de Vijver

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine